These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15545888)

  • 1. Melanoma metastasis to the testis demonstrated with FDG PET/CT.
    Weng LJ; Schöder H
    Clin Nucl Med; 2004 Dec; 29(12):811-2. PubMed ID: 15545888
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of malignant melanoma with cardiac and gallbladder metastases detected by FDG PET-CT.
    Ozülker T; Ozülker F; Cicin I; Ozpaçac T
    Clin Nucl Med; 2009 Dec; 34(12):948-9. PubMed ID: 20139846
    [No Abstract]   [Full Text] [Related]  

  • 3. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
    Basu S; Alavi A
    Clin Nucl Med; 2007 May; 32(5):388-9. PubMed ID: 17452870
    [No Abstract]   [Full Text] [Related]  

  • 4. Melanoma imaging with highly specific PET probes: ready for prime time?
    Minn H; Vihinen P
    J Nucl Med; 2011 Jan; 52(1):5-7. PubMed ID: 21149485
    [No Abstract]   [Full Text] [Related]  

  • 5. Gallbladder metastasis from malignant melanoma: diagnosis with FDG PET/CT.
    Rehani B; Strohmeyer P; Jacobs M; Mantil J
    Clin Nucl Med; 2006 Dec; 31(12):812-3. PubMed ID: 17117082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/Computed Tomography and Patient Outcomes in Melanoma.
    Rohren EM
    PET Clin; 2015 Apr; 10(2):243-54. PubMed ID: 25829089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
    Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
    Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of FDG PET-CT in cutaneous melanoma].
    Nicol I; Chuto G; Gaudy-Marqueste C; Brenot-Rossi I; Grob JJ; Richard MA
    Bull Cancer; 2008 Nov; 95(11):1089-101. PubMed ID: 19036682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of (18)F-FDG-PET/CT in early and late stages of high-risk cutaneous malignant melanoma.
    Gellén E; Sántha O; Janka E; Juhász I; Péter Z; Erdei I; Lukács R; Fedinecz N; Galuska L; Remenyik É; Emri G
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1938-44. PubMed ID: 25753249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmoplastic melanoma: true positive and false negative findings on F-18 FDG-PET/CT.
    Roarke MC; Nguyen BD; Pockaj BA
    Clin Nucl Med; 2008 Aug; 33(8):562-4. PubMed ID: 18645380
    [No Abstract]   [Full Text] [Related]  

  • 11. Verification of musculoskeletal FDG-PET-CT findings performed for melanoma staging.
    Mansour AA; Kelley MC; Hatmaker AR; Holt GE; Schwartz HS
    Ann Surg Oncol; 2010 Apr; 17(4):1144-51. PubMed ID: 19967460
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Ram-Wolff C; Vercellino L; Brice P; La Selva R; Bagot M
    Eur J Dermatol; 2017 Oct; 27(5):496-504. PubMed ID: 28721937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET in early stage cutaneous malignant melanoma.
    McIvor J; Siew T; Campbell A; McCarthy M
    J Med Imaging Radiat Oncol; 2014 Apr; 58(2):149-54; quiz 266. PubMed ID: 24690243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periarticular FDG Uptake on PET/CT in malignant melanoma-metastatic or misleading?
    Tan GJ; Lee ST; Berlangieri SU; Scott AM
    Ann Acad Med Singap; 2013 Mar; 42(3):159-60. PubMed ID: 23604508
    [No Abstract]   [Full Text] [Related]  

  • 15. Capsule endoscopy versus positron emission tomography for detection of small-bowel metastatic melanoma: a pilot study.
    Prakoso E; Fulham M; Thompson JF; Selby WS
    Gastrointest Endosc; 2011 Apr; 73(4):750-6. PubMed ID: 21288518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging?
    Mayerhoefer ME; Prosch H; Herold CJ; Weber M; Karanikas G
    Eur Radiol; 2012 Nov; 22(11):2451-7. PubMed ID: 22653282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorodeoxyglucose-PET in the management of malignant melanoma.
    Kumar R; Mavi A; Bural G; Alavi A
    Radiol Clin North Am; 2005 Jan; 43(1):23-33. PubMed ID: 15693645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
    Abbott RA; Acland KM; Harries M; O'Doherty M
    Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
    Reinhardt MJ; Joe AY; Jaeger U; Huber A; Matthies A; Bucerius J; Roedel R; Strunk H; Bieber T; Biersack HJ; Tüting T
    J Clin Oncol; 2006 Mar; 24(7):1178-87. PubMed ID: 16505438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.